APT Medical Inc - Asset Resilience Ratio
APT Medical Inc (688617) has an Asset Resilience Ratio of 8.63% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See APT Medical Inc short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2025)
This chart shows how APT Medical Inc's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see how large is APT Medical Inc's balance sheet.
Liquid Assets Composition Over Time
This chart breaks down APT Medical Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read APT Medical Inc debt and liabilities for a breakdown of total debt and financial obligations.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥296.01 Million | 8.63% |
| Total Liquid Assets | CN¥296.01 Million | 8.63% |
Asset Resilience Insights
- Limited Liquidity: APT Medical Inc maintains only 8.63% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
APT Medical Inc Industry Peers by Asset Resilience Ratio
Compare APT Medical Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Eurobio Scientific SA
PA:ALERS |
Medical Devices | 10.52% |
|
Profound Medical Corp
TO:PRN |
Medical Devices | 67.66% |
|
EBR Systems Inc
AU:EBR |
Medical Devices | 54.70% |
|
Epitomee Medical Ltd
TA:EPIT |
Medical Devices | 0.24% |
|
Cleo Diagnostics Ltd
AU:COV |
Medical Devices | 94.64% |
|
Aligned Genetics Inc
KQ:238120 |
Medical Devices | 2.22% |
Annual Asset Resilience Ratio for APT Medical Inc (2021–2025)
The table below shows the annual Asset Resilience Ratio data for APT Medical Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 6.85% | CN¥250.49 Million ≈ $36.65 Million |
CN¥3.66 Billion ≈ $534.88 Million |
+4.52pp |
| 2023-12-31 | 2.33% | CN¥60.00 Million ≈ $8.78 Million |
CN¥2.57 Billion ≈ $376.51 Million |
-37.26pp |
| 2022-12-31 | 39.59% | CN¥881.34 Million ≈ $128.97 Million |
CN¥2.23 Billion ≈ $325.73 Million |
-5.80pp |
| 2021-12-31 | 45.39% | CN¥913.72 Million ≈ $133.71 Million |
CN¥2.01 Billion ≈ $294.58 Million |
-- |
About APT Medical Inc
APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. It offers electrophysiology products, such as navigation systems, navigated catheters, mapping catheters, ablation catheters, transseptal needles and sheaths, and steerable sheaths; and interventional cardiology and peripheral products, including access, diagno… Read more